Imaging of Adverse Events Related to Checkpoint Inhibitor Therapy

Immunotherapy with checkpoint inhibitors (ICIs) is becoming standard of practice for an increasing number of cancer types. ICIs enhance T-cell action against the cancer cells. By unbalancing the immune system ICIs may cause dysimmune toxicities, a series of disorders broadly defined immune-related a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vani, Vanina, Regge, Daniele, Cappello, Giovanni, Gabelloni, Michela, Neri, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235714/
https://www.ncbi.nlm.nih.gov/pubmed/32294888
http://dx.doi.org/10.3390/diagnostics10040216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235714/
https://www.ncbi.nlm.nih.gov/pubmed/32294888
http://dx.doi.org/10.3390/diagnostics10040216

Ejemplares similares